(PETS) PetMed Express - Ratings and Ratios

PetMed Express, Inc. (NASDAQ:PETS) is a leading online pet pharmacy operating in the United States. The company specializes in providing prescription and non-prescription medications, health products, and supplies for dogs, cats, and horses. Its product portfolio includes flea and tick control products, bone and joint care items, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies. Additionally, it offers prescription medications such as heartworm preventatives, arthritis treatments, and generic substitutes. The company also sells pet food, beds, crates, and other related accessories. PetMed Express markets its products through its website, mobile app, customer support center, and direct mail campaigns, including brochures and postcards. Founded in 1996, the company is headquartered in Delray Beach, Florida, and operates under the web domain https://www.1800petmeds.com.

Based on the provided and , here is a 3-month forecast: - Technical Outlook: The stock is currently trading below its 20-day and 50-day moving averages (SMA 20: 4.59, SMA 50: 4.80), indicating bearish momentum. However, it is above its 200-day moving average (SMA 200: 4.27), suggesting potential support at current levels. The Average True Range (ATR: 0.28) indicates low volatility, implying stable price movements in the near term. - Fundamental Outlook: With a market cap of $92.33M and a P/S ratio of 0.37, the company is valued below its peers in the specialty retail sector. The high trailing P/E (447.00) suggests overvaluation relative to earnings, but the forward P/E (17.92) indicates expectations of improved profitability. The P/B ratio of 0.94 signals that the stock is trading near book value, which may attract value investors. Return on equity (RoE: 0.37) is modest, reflecting moderate profitability. Over the next three months, the stock is likely to trade in a narrow range between $3.50 and $4.50, with potential upside if earnings improve.